Patents by Inventor Hazel B. Breitz

Hazel B. Breitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130203725
    Abstract: A method for treatment of small cell lung cancer (SCLC) that does not respond to first-line treatment or that progresses following cessation of first-line organoplatinum chemotherapy is provided that includes the administration of picoplatin, optionally in conjunction with a regimen of best supportive care. Multiple doses of picoplatin can be administered. The picoplatin can also treat SCLC that has metastacized to the brain.
    Type: Application
    Filed: March 4, 2011
    Publication date: August 8, 2013
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: Hazel B. Breitz, Robert De Jager, Paul L. Weiden
  • Publication number: 20130202690
    Abstract: The invention provides an encapsulated unit dosage form for picoplatin that is adapted for oral administration of the picoplatin containing a substantially dry powder with about 20 to 55 wt % picoplatin in the physical form of a picoplatin particulate wherein an average picoplatin particle diameter is less than about 10 microns. The picoplatin particles are dispersed within the powder of the formulation which includes a substantially water-soluble, water-dispersible, or water-absorbing carbohydrate and an effective amount of up to about 5 wt % of a lubricant.
    Type: Application
    Filed: September 27, 2012
    Publication date: August 8, 2013
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: Alistair J. Leigh, Christopher A. Procyshyn, Angelica F. Phillips, Hazel B. Breitz
  • Publication number: 20120156199
    Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.
    Type: Application
    Filed: May 12, 2010
    Publication date: June 21, 2012
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
  • Publication number: 20120122825
    Abstract: The invention provides a method of treatment of metastatic hormone-refractory prostate cancer involving substantially as concurrent administration of picoplatin and docetaxel. Prednisone may also be administered. Dosages and dosing regimens are provided.
    Type: Application
    Filed: May 12, 2010
    Publication date: May 17, 2012
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: David A. Karlin MD, Hazel B. Breitz MD, Paul L. Weiden MD, Robert De Jager
  • Patent number: 8178564
    Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens. Dosages, dosing schedules, and ancillary treatments are described.
    Type: Grant
    Filed: February 6, 2009
    Date of Patent: May 15, 2012
    Assignee: Poniard Pharmaceuticals, Inc.
    Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
  • Patent number: 8173686
    Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.
    Type: Grant
    Filed: May 13, 2009
    Date of Patent: May 8, 2012
    Assignee: Poniard Pharmaceuticals, Inc.
    Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
  • Patent number: 8168662
    Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens. Dosages, dosing schedules, and ancillary treatments are described.
    Type: Grant
    Filed: July 23, 2009
    Date of Patent: May 1, 2012
    Assignee: Poniard Pharmaceuticals, Inc.
    Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
  • Patent number: 8168661
    Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.
    Type: Grant
    Filed: May 12, 2009
    Date of Patent: May 1, 2012
    Assignee: Poniard Pharmaceuticals, Inc.
    Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
  • Publication number: 20100260832
    Abstract: The present invention provides a method to treat ovarian cancer by the administration of effective amounts of picoplatin and doxorubicin.
    Type: Application
    Filed: May 17, 2010
    Publication date: October 14, 2010
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: Michael S. Perry, Hazel B. Breitz, Cheni Kwok, Robert De Jager
  • Publication number: 20100215727
    Abstract: Methods for stabilizing aqueous solutions of picoplatin are provided. Such stable, preferably aseptic solutions are particularly useful for preparing unit dosages of picoplatin for oral or intravenous administration, preferably in combination with at least one additional non-platinum anti-cancer agent.
    Type: Application
    Filed: December 10, 2009
    Publication date: August 26, 2010
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: Alistair J. Leigh, Ronald A. Martell, David A. Karlin, Cheni Kwok, Christopher A. Procyshyn, Hazel B. Breitz, Paul L. Weiden
  • Publication number: 20100178328
    Abstract: The present invention provides a method to treat ovarian cancer by the administration of effective amounts of picoplatin and pegylated liposomal doxorubicin.
    Type: Application
    Filed: December 10, 2009
    Publication date: July 15, 2010
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: Ronald A. Martell, David A. Karlin, Hazel B. Breitz, Paul L. Weiden
  • Publication number: 20100062056
    Abstract: The invention provides an encapsulated unit dosage form for picoplatin that is adapted for oral administration of the picoplatin containing a substantially dry powder with about 20 to 55 wt % picoplatin in the physical form of a picoplatin particulate wherein an average picoplatin particle diameter is less than about 10 microns. The picoplatin particles are dispersed within the powder of the formulation which includes a substantially water-soluble, water-dispersible, or water-absorbing carbohydrate and an effective amount of up to about 5 wt % of a lubricant.
    Type: Application
    Filed: August 5, 2009
    Publication date: March 11, 2010
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: Alistair J. Leigh, Christopher A. Procyshyn, Angelica Phillips, Hazel B. Breitz
  • Publication number: 20090306034
    Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.
    Type: Application
    Filed: May 13, 2009
    Publication date: December 10, 2009
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
  • Publication number: 20090275549
    Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.
    Type: Application
    Filed: May 12, 2009
    Publication date: November 5, 2009
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden
  • Publication number: 20090197854
    Abstract: The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens. Dosages, dosing schedules, and ancillary treatments are described.
    Type: Application
    Filed: February 6, 2009
    Publication date: August 6, 2009
    Applicant: Poniard Pharmaceuticals, Inc.
    Inventors: David A. Karlin, Hazel B. Breitz, Paul L. Weiden